Drug development does not stop after trial completion. Archived samples are often reanalyzed for biomarker discovery and post-market surveillance. This ongoing need supports the Clinical Trial Biorepository And Archiving Solution Market.
Long-term data retention policies require sponsors to preserve records for several years, sometimes even decades. Automated archival systems ensure safe...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt